247 related articles for article (PubMed ID: 19434552)
21. Modeling the role of environment in addiction.
Caprioli D; Celentano M; Paolone G; Badiani A
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Nov; 31(8):1639-53. PubMed ID: 17889978
[TBL] [Abstract][Full Text] [Related]
22. Drug addiction: a general review of new concepts and future challenges.
Qureshi NA; al-Ghamdy YS; al-Habeeb TA
East Mediterr Health J; 2000 Jul; 6(4):723-33. PubMed ID: 11794078
[TBL] [Abstract][Full Text] [Related]
23. The economics of drug abuse: a quantitative assessment of drug demand.
Hursh SR; Galuska CM; Winger G; Woods JH
Mol Interv; 2005 Feb; 5(1):20-8. PubMed ID: 15731502
[TBL] [Abstract][Full Text] [Related]
24. Functional neurotoxicity of drugs of abuse.
Pulvirenti L
Funct Neurol; 1993; 8(6):433-40. PubMed ID: 8150323
[TBL] [Abstract][Full Text] [Related]
25. What neurobiology cannot tell us about addiction.
Kalant H
Addiction; 2010 May; 105(5):780-9. PubMed ID: 19919596
[TBL] [Abstract][Full Text] [Related]
26. The effect of exposure to drugs on the processing of natural rewards.
Anselme P
Neurosci Biobehav Rev; 2009 Mar; 33(3):314-35. PubMed ID: 18955078
[TBL] [Abstract][Full Text] [Related]
27. Sex differences in the vulnerability to drug abuse: a review of preclinical studies.
Roth ME; Cosgrove KP; Carroll ME
Neurosci Biobehav Rev; 2004 Oct; 28(6):533-46. PubMed ID: 15527861
[TBL] [Abstract][Full Text] [Related]
28. Measuring the reinforcing strength of abused drugs.
Bergman J; Paronis CA
Mol Interv; 2006 Oct; 6(5):273-83. PubMed ID: 17035668
[TBL] [Abstract][Full Text] [Related]
29. Adenosine A(2A) receptors and their role in drug addiction.
Brown RM; Short JL
J Pharm Pharmacol; 2008 Nov; 60(11):1409-30. PubMed ID: 18957161
[TBL] [Abstract][Full Text] [Related]
30. Neurobiology of addiction versus drug use driven by lack of choice.
Ahmed SH; Lenoir M; Guillem K
Curr Opin Neurobiol; 2013 Aug; 23(4):581-7. PubMed ID: 23428657
[TBL] [Abstract][Full Text] [Related]
31. Intermittent adaptation. A theory of drug tolerance, dependence and addiction.
Peper A
Pharmacopsychiatry; 2009 May; 42 Suppl 1():S129-43. PubMed ID: 19434551
[TBL] [Abstract][Full Text] [Related]
32. Neurologic aspects of drug abuse.
Goforth HW; Murtaugh R; Fernandez F
Neurol Clin; 2010 Feb; 28(1):199-215. PubMed ID: 19932382
[TBL] [Abstract][Full Text] [Related]
33. Addiction and cognitive functions.
Spiga S; Lintas A; Diana M
Ann N Y Acad Sci; 2008 Oct; 1139():299-306. PubMed ID: 18991875
[TBL] [Abstract][Full Text] [Related]
34. Oxytocin as a potential mediator and modulator of drug addiction.
Sarnyai Z
Addict Biol; 2011 Apr; 16(2):199-201. PubMed ID: 21371175
[No Abstract] [Full Text] [Related]
35. Self-perception of drug abusers and addicts and investigators' perception of etiological factors of psychoactive drug addiction.
Brajević-Gizdić I; Mulić R; Pletikosa M; Kljajić Z
Coll Antropol; 2009 Mar; 33(1):225-31. PubMed ID: 19408630
[TBL] [Abstract][Full Text] [Related]
36. Learning about addiction from the genome.
Nestler EJ; Landsman D
Nature; 2001 Feb; 409(6822):834-5. PubMed ID: 11237002
[TBL] [Abstract][Full Text] [Related]
37. [In vitro assessment of neuropsychotoxicity of abused drugs using organotypic slice cultures].
Nakagawa T; Kaneko S
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2008 Jun; 43(3):166-71. PubMed ID: 18646642
[TBL] [Abstract][Full Text] [Related]
38. How do we determine which drug-induced neuroplastic changes are important?
Kalivas PW
Nat Neurosci; 2005 Nov; 8(11):1440-1. PubMed ID: 16251984
[TBL] [Abstract][Full Text] [Related]
39. Behavioral perspectives on the neuroscience of drug addiction.
Winger G; Woods JH; Galuska CM; Wade-Galuska T
J Exp Anal Behav; 2005 Nov; 84(3):667-81. PubMed ID: 16596985
[TBL] [Abstract][Full Text] [Related]
40. [Neurobiology and psychology of addictions].
Beine A; de Timary P; Hermans E
J Pharm Belg; 2006; 61(1):15-25. PubMed ID: 16669343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
